Literature DB >> 25052879

Correlates of having never been HIV tested among entrants to substance abuse treatment clinics: empiric findings from real-world New England settings.

Jeanne J Chadwick1, Leonardo F Andrade, Frederick L Altice, Nancy M Petry.   

Abstract

Routine testing is the cornerstone to identifying HIV, but not all substance abuse treatment patients have been tested. This study is a real-world evaluation of predictors of having never been HIV tested among patients initiating substance abuse treatment. Participants (N = 614) from six New England clinics were asked whether they had ever been HIV tested. Eighty-five patients (13.8%) reported having never been tested and were compared to those who had undergone testing. Clinic, male gender (adjusted odds ratio (AOR) = 1.91, 95% confidence interval (CI) = 1.07-3.41), and having fewer employment (AOR = 0.31; 95% CI = 0.11-0.88) and medical problems (AOR = 0.40, 95% CI = 0.17-0.99) were independently correlated with having never been HIV tested. Thus, there is still considerable room for improved testing strategies as a clinically significant minority of substance abuse patients have never undergone HIV testing when they initiate treatment.

Entities:  

Keywords:  HIV; HIV testing; clinical settings; substance abuse treatment

Mesh:

Year:  2014        PMID: 25052879      PMCID: PMC4780256          DOI: 10.1080/02791072.2014.915363

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  40 in total

1.  Reliability of drug users' self-reported HIV risk behaviors using a brief, 11-item scale.

Authors:  N M Petry
Journal:  Subst Use Misuse       Date:  2001-10       Impact factor: 2.164

2.  The reliability and validity of a scale to measure HIV risk-taking behaviour among intravenous drug users.

Authors:  S Darke; W Hall; N Heather; J Ward; A Wodak
Journal:  AIDS       Date:  1991-02       Impact factor: 4.177

3.  New data from the Addiction Severity Index. Reliability and validity in three centers.

Authors:  A T McLellan; L Luborsky; J Cacciola; J Griffith; F Evans; H L Barr; C P O'Brien
Journal:  J Nerv Ment Dis       Date:  1985-07       Impact factor: 2.254

4.  HIV risk behaviors in male substance abusers with and without antisocial personality disorder.

Authors:  J L Kelley; N M Petry
Journal:  J Subst Abuse Treat       Date:  2000-07

5.  Review of medical encounters in the 5 years before a diagnosis of HIV-1 infection: implications for early detection.

Authors:  Daniel Klein; Leo B Hurley; Deanna Merrill; Charles P Quesenberry
Journal:  J Acquir Immune Defic Syndr       Date:  2003-02-01       Impact factor: 3.731

6.  HIV testing attitudes, AIDS stigma, and voluntary HIV counselling and testing in a black township in Cape Town, South Africa.

Authors:  S C Kalichman; L C Simbayi
Journal:  Sex Transm Infect       Date:  2003-12       Impact factor: 3.519

7.  Potential barriers to seeking human immunodeficiency virus testing among adults in the United States: data from the 1998 National Health Interview Survey.

Authors:  Joseph N Inungu
Journal:  AIDS Patient Care STDS       Date:  2002-06       Impact factor: 5.078

8.  Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence.

Authors:  Jesús Castilla; Paz Sobrino; Luis De La Fuente; Isabel Noguer; Luis Guerra; Francisco Parras
Journal:  AIDS       Date:  2002-09-27       Impact factor: 4.177

9.  Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings.

Authors:  Mark Dybul; Robert Bolan; David Condoluci; Roxane Cox-Iyamu; Robert Redfield; Claire W Hallahan; Marlene Folino; Kunthavi Sathasivam; Monica Weisberg; Maryann Andrews; Bertha Hidalgo; Joshua Vasquez; Anthony S Fauci
Journal:  J Infect Dis       Date:  2002-05-31       Impact factor: 5.226

10.  Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom?

Authors:  Nancy M Petry; Jacqueline Tedford; Mark Austin; Charla Nich; Kathleen M Carroll; Bruce J Rounsaville
Journal:  Addiction       Date:  2004-03       Impact factor: 6.526

View more
  5 in total

1.  Assessment of an Innovative Voluntary Substance Abuse Treatment Program Designed to Replace Compulsory Drug Detention Centers in Malaysia.

Authors:  Farrah Khan; Archana Krishnan; Mansur A Ghani; Jeffrey A Wickersham; Jeannia J Fu; Sin How Lim; Sangeeth Kaur Dhaliwal; Adeeba Kamarulzaman; Frederick L Altice
Journal:  Subst Use Misuse       Date:  2017-02-22       Impact factor: 2.164

2.  Measuring Acceptability and Preferences for Implementation of Pre-Exposure Prophylaxis (PrEP) Using Conjoint Analysis: An Application to Primary HIV Prevention Among High Risk Drug Users.

Authors:  Roman Shrestha; Pramila Karki; Frederick L Altice; Oleksandr Dubov; Liana Fraenkel; Tania Huedo-Medina; Michael Copenhaver
Journal:  AIDS Behav       Date:  2018-04

3.  Buprenorphine maintenance treatment retention improves nationally recommended preventive primary care screenings when integrated into urban federally qualified health centers.

Authors:  Marwan S Haddad; Alexei Zelenev; Frederick L Altice
Journal:  J Urban Health       Date:  2015-02       Impact factor: 3.671

Review 4.  Challenges in managing HIV in people who use drugs.

Authors:  Adeeba Kamarulzaman; Frederick L Altice
Journal:  Curr Opin Infect Dis       Date:  2015-02       Impact factor: 4.915

5.  The Pre-exposure Prophylaxis (PrEP) Care Cascade in People Who Inject Drugs: A Systematic Review.

Authors:  Colleen B Mistler; Michael M Copenhaver; Roman Shrestha
Journal:  AIDS Behav       Date:  2021-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.